Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6022534

Title:Lymphotactin uses
Inventors:Hedrick, Joseph A.; Plainsboro, NJ, USA
Hudak, SUSA
n A.; Redwood City, CA, USA
Zlotnik, Albert; Palo Alto, CA, USA
Summary:Described herein are methods of lymphotactin use in increasing local populations of natural killer cells and cytotoxic T lymphocyte cells in mammals. The invention relates to the use of lymphotactin or lymphotactin antagonists for therapeutic administration to a mammal for the purpose either of attracting certain cell types or of blocking and preventing such an attraction. Methods of protecting stem cells with lymphotactin and its antagonists are further disclosed. Also included are therapeutic and experimental applications.
Abstract:This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6022534
Application Number:US1997000956250
Date Filed:22/10/1997
Date Published:08/02/2000
Assignee:Schering Corporation, Kenilworth, NJ, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/18/2021